Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: A 2-year follow-up study

Journal of Clinical Oncology

Volumn 27, Issue 12, 2009, Pages 2007-2014

  Shih, Ya Chen Tina ^a,d   Xu, Ying ^b   Cormier, Janice N ^b   Giordano, Sharon ^b   Ridner, Sheila H ^c   Buchholz, Thomas A ^a   Perkins, George H ^a   Elting, Linda S ^a  

^a Section of Health Services Research   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BOOTSTRAPPING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER THERAPY; CELLULITIS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INCIDENCE; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE DISSECTION; LYMPHANGITIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MENTAL HEALTH SERVICE; OUTPATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; INCIDENCE; INSURANCE CLAIM REVIEW; LYMPHEDEMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 65349141943     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.3517     Document Type: Article

References (55)

1. Hayes SC, Janda M, Cornish B, et al: Lymphedema after breast cancer: Incidence, risk factors, and effect on upper body function. J Clin Oncol 26:3536-3542, 2008
2. Petrek JA, Pressman PI, Smith RA: Lymphed-ema: Current issues in research and management. CA Cancer J Clin 50:292-307, 2000
3. Armer JM, Porock D: Self-management of fatigue among women with lymphedema. Lymphol-ogy 35:208-213, 2002
4. Beaulac SM, McNair LA, Scott TE, et al: Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg 137:1253-1257, 2002
5. Heiney SP, McWayne J, Cunningham JE, et al: Quality of life and lymphedema following breast cancer. Lymphology 40:177-184, 2007
6. Kakuda JT, Stuntz M, Trivedi V, et al: Objective assessment of axillary morbidity in breast cancer treatment. Am Surg 65:995-998, 1999
7. McWayne J, Heiney SP: Psychologic and social sequelae of secondary lymphedema: A review. Cancer 104:457-466, 2005
8. Pyszel A, Malyszczak K, Pyszel K, et al: Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology 39:185-192, 2006
9. Voogd AC, Ververs JM, Vingerhoets AJ, et al: Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg 90:76-81, 2003
10. Grabsch B, Clarke DM, Love A, et al: Psychological morbidity and quality of life in women with advanced breast cancer: A cross-sectional survey. Palliat Support Care 4:47-56, 2006
11. Coen JJ, Taghian AG, Kachnic LA, et al: Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 55:1209-1215, 2003
12. Golshan M, Martin WJ, Dowlatshahi K: Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69:209-211, 2003
13. Herd-Smith A, Russo A, Muraca MG, et al: Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 92:1783-1787, 2001
14. Kosir M, Rymal C, Koppolu P, et al: Surgical outcomes after breast cancer surgery: Measuring acute lymphedema. J Surg Res 95:147-151, 2001
15. Meric F, Buchholz TA, Mirza NQ, et al: Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9:543-549, 2002
16. Paskett ED, Naughton MJ, McCoy TP, et al: The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 16:775-782, 2007
17. Schijven MP, Vingerhoets AJ, Rutten HJ, et al: Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29:341-350, 2003
18. Schrenk P, Rieger R, Shamiyeh A, et al: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608-614, 2000
19. Sener SF, Winchester DJ, Martz CH, et al: Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92:748-752, 2001
20. Tengrup I, Tennvall-Nittby L, Christiansson I, et al: Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol 39:393-397, 2000
21. Armer JM: The problem of post-breast cancer lymphedema: Impact and measurement issues. Cancer Invest 23:76-83, 2005
22. Hayes S, Janda M, Cornish B, et al: Lymphed-ema secondary to breast cancer: How choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology 41:18-28, 2008
23. Williams AF, Franks PJ, Moffatt CJ: Lymph-oedema: Estimating the size of the problem. Palliat Med 19:300-313, 2005
24. Erickson VS, Pearson ML, Ganz PA, et al: Arm edema in breast cancer patients. J Natl Cancer Inst 93:96-111, 2001
25. Johansson K, Ohlsson K, Ingvar C, et al: Factors associated with the development of arm lymphedema following breast cancer treatment: A match pair case-control study. Lymphology 35:59-71, 2002
26. Kocak Z, Overgaard J: Risk factors of arm lymphedema in breast cancer patients. Acta Oncol 39:389-392, 2000
27. Ozaslan C, Kuru B: Lymphedema after treatment of breast cancer. Am J Surg 187:69-72, 2004
28. Golshan M, Smith B: Prevention and management of arm lymphedema in the patient with breast cancer. J Support Oncol 4:381-386, 2006
29. Mansel RE, Fallowfield L, Kissin M, et al: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 98:599-609, 2006
30. Sakorafas GH, Peros G, Cataliotti L, et al: Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15:153-165, 2006
31. Soran A, D'Angelo G, Begovic M, et al: Breast cancer-related lymphedema: What are the significant predictors and how they affect the severity of lymphedema? Breast J 12:536-543, 2006
32. Geller BM, Vacek PM, O'Brien P, et al: Factors associated with arm swelling after breast cancer surgery. J Womens Health 12:921-930, 2003
33. Hinrichs CS, Watroba NL, Rezaishiraz H, et al: Lymphedema secondary to postmastectomy radiation: Incidence and risk factors. Ann Surg Oncol 11:573-580, 2004
34. Sparaco A, Fentiman IS: Arm lymphoedema following breast cancer treatment. Int J Clin Pract 56:107-110, 2002
35. Langer I, Guller U, Berclaz G, et al: Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: A prospective Swiss multicenter study on 659 patients. Ann Surg 245: 452-461, 2007
36. Lucci A, McCall LM, Beitsch PD, et al: Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657-3663, 2007
37. Moseley AL, Carati CJ, Piller NB: A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol 18:639-646, 2007
38. Warren AG, Brorson H, Borud LJ, et al: Lymphedema: A comprehensive review. Ann Plast Surg 59:464-472, 2007
39. Mason W: Exploring rehabilitation within lym-phoedema management. Int J Palliat Nurs 6:265-268, 270-273, 2000
40. Armer JM, Radina ME, Porock D, et al: Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 52:370-379, 2003
41. Medstat: 1997-2001 MarketScan Health and Productivity Management Databases: User Guide and Database Dictionary. Ann Arbor, MI, MarketScan Database, Thomson Medstat, 2003
42. Nattinger AB, Laud PW, Bajorunaite R, et al: An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Health Serv Res 39:1733-1749, 2004
43. Edwards TL: Prevalence and aetiology of lym-phoedema after breast cancer treatment in southern Tasmania. Aust N Z J Surg 70:412-418, 2000
44. Medicare Report: A Quarterly Newsletter for Medicare Providers, March 1998. www.pennsylvani amedicare.com/partb/med-reports/pdf/mr0398.pdf
45. Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000
46. Karon JM, Kupper LL: In defense of matching. Am J Epidemiol 116:852-866, 1982
47. Kupper LL, Karon JM, Kleinbaum DG, et al: Matching in epidemiologic studies: Validity and efficiency considerations. Biometrics 37:271-291, 1981
48. Doshi JA, Glick HA, Polsky D: Analyses of cost data in economic evaluations conducted alongside randomized controlled trials. Value Health 9:334-340, 2006
49. Duan N, Manning WG, Morris C, et al: A comparison of alternative models for the demands for medical care. J Business Econ Stat 1:115-126, 1983
50. Manning WG: The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 17:283-295, 1998
51. Larson MJ, Miller K, Fleming KJ, et al: Mental health services for children in large, employer-based health plans, 1999. J Behav Health Serv Res 34:56-72, 2007
52. Hillner BE, Mandelblatt J: Caring for older women with breast cancer: Can observational research fill the clinical trial gap? J Natl Cancer Inst 98:660-661, 2006
53. National Cancer Institute: State laws requiring specified third-party payers to offer or provide coverage for lymphedema treatment incident to breast cancer. http://www.scld-nci.net/Data/Lymphedema-12-31-06.pdf
54. American Cancer Society: Women's Health and Cancer Rights Act. http://www.cancer.org/ docroot/MIT/content/MIT-3-2X.asp
55. Moffatt CJ, Franks PJ, Doherty DC, et al: Lymphoedema: An underestimated health problem. QJM 96:731-738, 2003